News
Firehawk Liberty™ Receives Registration Approval in Egypt - 23 Feb 2022
Firehawk Liberty™ recently received registration approval from the Cen...MicroPort® MedBot® Announces Inclusion in Hang Seng Composite Index - 22 Feb 2022
MicroPort® MedBot® has announced the company has been selected for inc...NeuroTech™ NUMEN® Listed for Reimbursement under Korea’s Insurance - 22 Feb 2022
MicroPort NeuroTech™ has recently received marketing approval from Chi...MicroPort® Holds Singapore LIVE 2022 Satellite Session on Complex Lesions - 10 Feb 2022
Singapore LIVE 2022, an Asian academic conference in the field of card...MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk® 3-D Coil Embolization System - 09 Feb 2022
MicroPort NeuroTech™ has received marketing approval from China’s Nati...MicroPort® Toumai® Surgical Robot Receives NMPA Approval, Becoming the First Commercialized Four-Arm Laparoscopic Surgical Robot Developed in China - 27 Jan 2022
MicroPort® MedBot® recently announced that its Toumai® Laparoscopic Su...MicroPort NeuroTech™ Receives NMPA Marketing Approval for its Diveer® Intracranial Balloon Catheter - 27 Jan 2022
MicroPort NeuroTech™ has received marketing approval from China’s Nati...MicroPort® Orthopedics Receives NMPA Marketing Approval for its Procotyl®-L Acetabular Cup System and Profemur® Preserve Hip Stem - 27 Jan 2022
MicroPort® Orthopedics recently announced that it has received registr...First Patient Enrolled in MicroPort NueroTech™ PROMISE Study for Rebridge® Intracranial Visualized Stent - 27 Jan 2022
MicroPort NeuroTech™ recently announced that it has enrolled the first...MicroPort® RehabTech Launches New Integrated Musculoskeletal Rehabilitation Solution - 26 Jan 2022
MicroPort® RehabTech recently unveiled a series of new products under ...MicroPort® HorizonMedical™ Receives Marketing Approval for Two Oocyte Retrieval Needles - 26 Jan 2022
HorizonMedical™ recently received registration approval from the Zheji...Single-Use Flexible Ureteropelvic Electronic Endoscopic Catheter developed by MicroPort® Urocare Approved for Marketing - 25 Jan 2022
MicroPort® Urocare recently obtained medical device registration certi...TARGET PREMIER Clinical Study for MicroPort® Next Generation Rapamycin Target Eluting Stent Completes First Patient Enrollment - 25 Jan 2022
Recently, the TARGET PREMIER project, a pre-market clinical study of t...REVEDA Establishes Joint Venture with Hybio Pharmaceutical on Drug-Device Combination Products - 25 Jan 2022
REVEDA recently announced that it has entered into an agreement with H...Toumai® Laparoscopic Surgical Robot by MicroPort® MedBot® Completes Enrollment for Multidisciplinary, Multicenter-Registered Clinical Trials - 25 Jan 2022
Toumai® laparoscopic surgical robot successfully performed two hepatot...MicroPort® Orthopedics China Develops "Personalized" Artificial Wrist Prosthesis - 15 Jan 2022
MicroPort® Orthopedics China has developed a “personalized and precise...